Gino Kenny (Dublin Mid West, People Before Profit Alliance) | Oireachtas source

I have a quick question, which is important. I refer to those 67 individuals who have a ministerial licence. They would currently fall outside the MCAP. For logistical reasons and because of the product they get from the Netherlands, that cannot be included on the schedule. That could be overcome. Denmark has a third party licence company that provides that product to the Danish medicinal cannabis access programme. In this situation with 67 individuals, they are not monitored collectively, so in that situation could they be included in the programme as part of the monitoring process? The vast majority of them would in the programme because of refractory epilepsy. Could they be part of the programme, not be prescribed medicinal cannabis products under the schedule, but be monitored nonetheless?